Correction to: British Journal of Cancer (2008) 98, 1085–1093. doi:10.1038/sj.bjc.6604281
During revision and subsequent submission of the above paper to the journal, an author's name, Rajmohan Murali, was omitted from the authors list. The complete list of authors is given above.
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Additional information
The online version of the original article can be found at 10.1038/sj.bjc.6604281
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
O'Brien, P., Davies, M., Scurry, J. et al. Erratum: The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. Br J Cancer 98, 1880 (2008). https://doi.org/10.1038/sj.bjc.6604419
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6604419
